Elixxer Stock Market Value
| ELIXF Stock | USD 0.01 0.00 0.00% |
| Symbol | Elixxer |
Elixxer 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Elixxer's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Elixxer.
| 12/18/2025 |
| 01/17/2026 |
If you would invest 0.00 in Elixxer on December 18, 2025 and sell it all today you would earn a total of 0.00 from holding Elixxer or generate 0.0% return on investment in Elixxer over 30 days. Elixxer is related to or competes with Willow Biosciences, 1CM, Vext Science, and C21 Investments. Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland More
Elixxer Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Elixxer's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Elixxer upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 57.02 | |||
| Information Ratio | 0.1006 | |||
| Maximum Drawdown | 719.3 | |||
| Value At Risk | (19.27) | |||
| Potential Upside | 31.96 |
Elixxer Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Elixxer's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Elixxer's standard deviation. In reality, there are many statistical measures that can use Elixxer historical prices to predict the future Elixxer's volatility.| Risk Adjusted Performance | 0.0805 | |||
| Jensen Alpha | 7.7 | |||
| Total Risk Alpha | (2.36) | |||
| Sortino Ratio | 0.1455 | |||
| Treynor Ratio | 1.11 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Elixxer's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Elixxer Backtested Returns
Elixxer is out of control given 3 months investment horizon. Elixxer secures Sharpe Ratio (or Efficiency) of 0.0919, which denotes the company had a 0.0919 % return per unit of risk over the last 3 months. We have analyzed and interpolated twenty-four different technical indicators, which can help you to evaluate if expected returns of 7.75% are justified by taking the suggested risk. Use Elixxer Downside Deviation of 57.02, coefficient of variation of 982.2, and Mean Deviation of 23.27 to evaluate company specific risk that cannot be diversified away. Elixxer holds a performance score of 7 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 7.54, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Elixxer will likely underperform. Use Elixxer total risk alpha, as well as the relationship between the potential upside and kurtosis , to analyze future returns on Elixxer.
Auto-correlation | 0.00 |
No correlation between past and present
Elixxer has no correlation between past and present. Overlapping area represents the amount of predictability between Elixxer time series from 18th of December 2025 to 2nd of January 2026 and 2nd of January 2026 to 17th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Elixxer price movement. The serial correlation of 0.0 indicates that just 0.0% of current Elixxer price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | -0.5 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Elixxer lagged returns against current returns
Autocorrelation, which is Elixxer pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Elixxer's pink sheet expected returns. We can calculate the autocorrelation of Elixxer returns to help us make a trade decision. For example, suppose you find that Elixxer has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Elixxer regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Elixxer pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Elixxer pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Elixxer pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Elixxer Lagged Returns
When evaluating Elixxer's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Elixxer pink sheet have on its future price. Elixxer autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Elixxer autocorrelation shows the relationship between Elixxer pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Elixxer.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Elixxer Pink Sheet
Elixxer financial ratios help investors to determine whether Elixxer Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Elixxer with respect to the benefits of owning Elixxer security.